H. R. 1625—369 
502(b)(1) of the Social Security Act, not more than $83,593,000 
shall be available for carrying out special projects of regional and 
national significance pursuant to section 501(a)(2) of such Act and 
$10,276,000 shall be available for projects described in subpara-
graphs (A) through (F) of section 501(a)(3) of such Act. 
RYAN WHITE HIV/AIDS PROGRAM 
For carrying out title XXVI of the PHS Act with respect to 
the Ryan White HIV/AIDS program, $2,318,781,000, of which 
$1,970,881,000 shall remain available to the Secretary through 
September 30, 2020, for parts A and B of title XXVI of the PHS 
Act, and of which not less than $900,313,000 shall be for State 
AIDS Drug Assistance Programs under the authority of section 
2616 or 311(c) of such Act. 
HEALTH CARE SYSTEMS 
For carrying out titles III and XII of the PHS Act with respect 
to health care systems, and the Stem Cell Therapeutic and Research 
Act of 2005, $111,693,000, of which $122,000 shall be available 
until expended for facilities renovations at the Gillis W. Long 
Hansen’s Disease Center. 
RURAL HEALTH 
For carrying out titles III and IV of the PHS Act with respect 
to rural health, section 427(a) of the Federal Coal Mine Health 
and Safety Act of 1969, and sections 711 and 1820 of the Social 
Security Act, $290,794,000, of which $49,609,000 from general reve-
nues, notwithstanding section 1820(j) of the Social Security Act, 
shall be available for carrying out the Medicare rural hospital 
flexibility grants program: Provided, That of the funds made avail-
able under this heading for Medicare rural hospital flexibility 
grants, $15,942,000 shall be available for the Small Rural Hospital 
Improvement Grant Program for quality improvement and adoption 
of health information technology and up to $1,000,000 shall be 
to carry out section 1820(g)(6) of the Social Security Act, with 
funds provided for grants under section 1820(g)(6) available for 
the purchase and implementation of telehealth services, including 
pilots and demonstrations on the use of electronic health records 
to coordinate rural veterans care between rural providers and the 
Department of Veterans Affairs electronic health record system: 
Provided further, That notwithstanding section 338J(k) of the PHS 
Act, $10,000,000 shall be available for State Offices of Rural Health: 
Provided further, That $15,000,000 shall remain available through 
September 30, 2020 to support the Rural Residency Development 
Program: Provided further, That $100,000,000 shall remain avail-
able through September 30, 2022, for the Rural Communities 
Opioids Response Program. 
FAMILY PLANNING 
For carrying out the program under title X of the PHS Act 
to provide for voluntary family planning projects, $286,479,000: 
Provided, That amounts provided to said projects under such title 
shall not be expended for abortions, that all pregnancy counseling 
shall be nondirective, and that such amounts shall not be expended
H. R. 1625—370 
for any activity (including the publication or distribution of lit-
erature) that in any way tends to promote public support or opposi-
tion to any legislative proposal or candidate for public office. 
PROGRAM MANAGEMENT 
For program support in the Health Resources and Services 
Administration, $155,000,000: Provided, That funds made available 
under this heading may be used to supplement program support 
funding provided under the headings ‘‘Primary Health Care’’, 
‘‘Health Workforce’’, ‘‘Maternal and Child Health’’, ‘‘Ryan White 
HIV/AIDS Program’’, ‘‘Health Care Systems’’, and ‘‘Rural Health’’. 
VACCINE INJURY COMPENSATION PROGRAM TRUST FUND 
For payments from the Vaccine Injury Compensation Program 
Trust Fund (the ‘‘Trust Fund’’), such sums as may be necessary 
for claims associated with vaccine-related injury or death with 
respect to vaccines administered after September 30, 1988, pursuant 
to subtitle 2 of title XXI of the PHS Act, to remain available 
until expended: Provided, That for necessary administrative 
expenses, not to exceed $9,200,000 shall be available from the 
Trust Fund to the Secretary. 
CENTERS FOR DISEASE CONTROL AND PREVENTION 
IMMUNIZATION AND RESPIRATORY DISEASES 
For carrying out titles II, III, XVII, and XXI, and section 
2821 of the PHS Act, titles II and IV of the Immigration and 
Nationality Act, and section 501 of the Refugee Education Assist-
ance Act, with respect to immunization and respiratory diseases, 
$474,055,000. 
HIV/AIDS, VIRAL HEPATITIS, SEXUALLY TRANSMITTED DISEASES, AND 
TUBERCULOSIS PREVENTION 
For carrying out titles II, III, XVII, and XXIII of the PHS 
Act with respect to HIV/AIDS, viral hepatitis, sexually transmitted 
diseases, and tuberculosis prevention, $1,127,278,000. 
EMERGING AND ZOONOTIC INFECTIOUS DISEASES 
For carrying out titles II, III, and XVII, and section 2821 
of the PHS Act, titles II and IV of the Immigration and Nationality 
Act, and section 501 of the Refugee Education Assistance Act, 
with respect to emerging and zoonotic infectious diseases, 
$562,572,000. 
CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION 
For carrying out titles II, III, XI, XV, XVII, and XIX of the 
PHS Act with respect to chronic disease prevention and health 
promotion, $915,346,000: Provided, That funds appropriated under 
this account may be available for making grants under section 
1509 of the PHS Act for not less than 21 States, tribes, or tribal 
organizations: Provided further, That of the funds made available 
under this heading, $15,000,000 shall be available to continue and 
expand community specific extension and outreach programs to
H. R. 1625—371 
combat obesity in counties with the highest levels of obesity: Pro-
vided further, That the proportional funding requirements under 
section 1503(a) of the PHS Act shall not apply to funds made 
available under this heading. 
BIRTH DEFECTS, DEVELOPMENTAL DISABILITIES, DISABILITIES AND 
HEALTH 
For carrying out titles II, III, XI, and XVII of the PHS Act 
with respect to birth defects, developmental disabilities, disabilities 
and health, $140,560,000. 
PUBLIC HEALTH SCIENTIFIC SERVICES 
For carrying out titles II, III, and XVII of the PHS Act with 
respect to health statistics, surveillance, health informatics, and 
workforce development, $490,397,000. 
ENVIRONMENTAL HEALTH 
For carrying out titles II, III, and XVII of the PHS Act with 
respect to environmental health, $188,750,000. 
INJURY PREVENTION AND CONTROL 
For carrying out titles II, III, and XVII of the PHS Act with 
respect to injury prevention and control, $648,559,000, of which 
$475,579,000 shall remain available until September 30, 2019 for 
an evidence-based opioid drug overdose prevention program. 
NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH 
For carrying out titles II, III, and XVII of the PHS Act, sections 
101, 102, 103, 201, 202, 203, 301, and 501 of the Federal Mine 
Safety and Health Act, section 13 of the Mine Improvement and 
New Emergency Response Act, and sections 20, 21, and 22 of 
the Occupational Safety and Health Act, with respect to occupa-
tional safety and health, $335,200,000. 
ENERGY EMPLOYEES OCCUPATIONAL ILLNESS COMPENSATION 
PROGRAM 
For necessary expenses to administer the Energy Employees 
Occupational Illness Compensation Program Act, $55,358,000, to 
remain available until expended: Provided, That this amount shall 
be available consistent with the provision regarding administrative 
expenses in section 151(b) of division B, title I of Public Law 
106–554. 
GLOBAL HEALTH 
For carrying out titles II, III, and XVII of the PHS Act with 
respect to global health, $488,621,000, of which (1) $128,421,000 
shall remain available through September 30, 2019 for international 
HIV/AIDS and (2) $50,000,000 shall remain available through Sep-
tember 30, 2020 for Global Disease Detection and Emergency 
Response: Provided, That funds may be used for purchase and 
insurance of official motor vehicles in foreign countries.
H. R. 1625—372 
PUBLIC HEALTH PREPAREDNESS AND RESPONSE 
For carrying out titles II, III, and XVII of the PHS Act with 
respect to public health preparedness and response, and for 
expenses necessary to support activities related to countering poten-
tial biological, nuclear, radiological, and chemical threats to civilian 
populations, $1,450,000,000, of which $610,000,000 shall remain 
available until expended for the Strategic National Stockpile: Pro-
vided, That in the event the Director of the Centers for Disease 
Control and Prevention (referred to in this title as ‘‘CDC’’) activates 
the Emergency Operations Center, the Director of the CDC may 
detail CDC staff without reimbursement for up to 90 days to support 
the work of the CDC Emergency Operations Center, so long as 
the Director provides a notice to the Committees on Appropriations 
of the House of Representatives and the Senate within 15 days 
of the use of this authority and a full report within 30 days after 
use of this authority which includes the number of staff and funding 
level broken down by the originating center and number of days 
detailed: Provided further, That funds appropriated under this 
heading may be used to support a contract for the operation and 
maintenance of an aircraft in direct support of activities throughout 
CDC to ensure the agency is prepared to address public health 
preparedness emergencies. 
BUILDINGS AND FACILITIES 
(INCLUDING TRANSFER OF FUNDS) 
For acquisition of real property, equipment, construction, demo-
lition, and renovation of facilities, $270,000,000, which shall remain 
available until September 30, 2022, of which $240,000,000 shall 
be for a CDC biosafety level 4 laboratory: Provided, That in addition 
to the amount provided, $240,000,000 shall be for a CDC biosafety 
level 4 laboratory for the purposes described in the previous proviso 
and shall be derived by transfer from the Fund established by 
Public Law 110–161, division G, title II, section 223 and shall 
remain available until September 30, 2022: Provided further, That 
funds previously set-aside by CDC for repair and upgrade of the 
Lake Lynn Experimental Mine and Laboratory shall be used to 
acquire a replacement mine safety research facility: Provided fur-
ther, That in addition, the prior year unobligated balance of any 
amounts assigned to former employees in accounts of CDC made 
available for Individual Learning Accounts shall be credited to 
and merged with the amounts made available under this heading 
to support the replacement of the mine safety research facility. 
CDC-WIDE ACTIVITIES AND PROGRAM SUPPORT 
For carrying out titles II, III, XVII and XIX, and section 2821 
of the PHS Act and for cross-cutting activities and program support 
for activities funded in other appropriations included in this Act 
for the Centers for Disease Control and Prevention, $113,570,000: 
Provided, That paragraphs (1) through (3) of subsection (b) of section 
2821 of the PHS Act shall not apply to funds appropriated under 
this heading and in all other accounts of the CDC: Provided further, 
That employees of CDC or the Public Health Service, both civilian 
and commissioned officers, detailed to States, municipalities, or 
other organizations under authority of section 214 of the PHS
H. R. 1625—373 
Act, or in overseas assignments, shall be treated as non-Federal 
employees for reporting purposes only and shall not be included 
within any personnel ceiling applicable to the Agency, Service, 
or HHS during the period of detail or assignment: Provided further, 
That CDC may use up to $10,000 from amounts appropriated 
to CDC in this Act for official reception and representation expenses 
when specifically approved by the Director of CDC: Provided further, 
That in addition, such sums as may be derived from authorized 
user fees, which shall be credited to the appropriation charged 
with the cost thereof: Provided further, That with respect to the 
previous proviso, authorized user fees from the Vessel Sanitation 
Program and the Respirator Certification Program shall be available 
through September 30, 2019. 
NATIONAL INSTITUTES OF HEALTH 
NATIONAL CANCER INSTITUTE 
For carrying out section 301 and title IV of the PHS Act 
with respect to cancer, $5,664,800,000, of which up to $30,000,000 
may be used for facilities repairs and improvements at the National 
Cancer Institute—Frederick Federally Funded Research and 
Development Center in Frederick, Maryland. 
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE 
For carrying out section 301 and title IV of the PHS Act 
with respect to cardiovascular, lung, and blood diseases, and blood 
and blood products, $3,383,201,000. 
NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH 
For carrying out section 301 and title IV of the PHS Act 
with respect to dental and craniofacial diseases, $447,735,000. 
NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY 
DISEASES 
For carrying out section 301 and title IV of the PHS Act 
with respect to diabetes and digestive and kidney disease, 
$1,970,797,000. 
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE 
For carrying out section 301 and title IV of the PHS Act 
with respect to neurological disorders and stroke, $2,145,149,000: 
Provided, That $250,000,000 shall be available until September 
30, 2019 for research related to opioid addiction, development of 
opioid alternatives, pain management, and addiction treatment: 
Provided further, That each for-profit recipient of funds provided 
in the previous proviso shall be subject to a matching requirement 
of funds or documented in-kind contributions of not less than 50 
percent of the total funds awarded to such entity. 
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES 
For carrying out section 301 and title IV of the PHS Act 
with respect to allergy and infectious diseases, $5,260,210,000.
H. R. 1625—376 
of the PHS Act, relating to the Cures Acceleration Network: Pro-
vided further, That at least $542,771,000 is provided to the Clinical 
and Translational Sciences Awards program. 
OFFICE OF THE DIRECTOR 
For carrying out the responsibilities of the Office of the Director, 
NIH, $1,803,293,000: Provided, That funding shall be available 
for the purchase of not to exceed 29 passenger motor vehicles 
for replacement only: Provided further, That all funds credited 
to the NIH Management Fund shall remain available for one fiscal 
year after the fiscal year in which they are deposited: Provided 
further, That $165,000,000 shall be for the National Children’s 
Study Follow-on: Provided further, That $588,116,000 shall be avail-
able for the Common Fund established under section 402A(c)(1) 
of the PHS Act: Provided further, That of the funds provided, 
$10,000 shall be for official reception and representation expenses 
when specifically approved by the Director of the NIH: Provided 
further, That the Office of AIDS Research within the Office of 
the Director of the NIH may spend up to $8,000,000 to make 
grants for construction or renovation of facilities as provided for 
in section 2354(a)(5)(B) of the PHS Act. 
In addition to other funds appropriated for the Common Fund 
established under section 402A(c) of the PHS Act, $12,600,000 
is appropriated to the Common Fund for the purpose of carrying 
out section 402(b)(7)(B)(ii) of the PHS Act (relating to pediatric 
research), as authorized in the Gabriella Miller Kids First Research 
Act. 
BUILDINGS AND FACILITIES 
For the study of, construction of, demolition of, renovation 
of, and acquisition of equipment for, facilities of or used by NIH, 
including the acquisition of real property, $128,863,000, to remain 
available through September 30, 2022. 
NIH INNOVATION ACCOUNT, CURES ACT 
For necessary expenses to carry out the purposes described 
in section 1001(b)(4) of the 21st Century Cures Act, in addition 
to amounts available for such purposes in the appropriations pro-
vided to the NIH in this Act, $496,000,000, to remain available 
until expended: Provided, That such amounts are appropriated 
pursuant to section 1001(b)(3) of such Act, are to be derived from 
amounts transferred under section 1001(b)(2)(A) of such Act, and 
may be transferred by the Director of the National Institutes of 
Health to other accounts of the National Institutes of Health solely 
for the purposes provided in such Act: Provided further, That upon 
a determination by the Director that funds transferred pursuant 
to the previous proviso are not necessary for the purposes provided, 
such amounts may be transferred back to the Account: Provided 
further, That the transfer authority provided under this heading 
is in addition to any other transfer authority provided by law.
H. R. 1625—377 
SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES ADMINISTRATION 
MENTAL HEALTH 
For carrying out titles III, V, and XIX of the PHS Act with 
respect to mental health, and the Protection and Advocacy for 
Individuals with Mental Illness Act, $1,453,972,000: Provided, That 
notwithstanding section 520A(f)(2) of the PHS Act, no funds appro-
priated for carrying out section 520A shall be available for carrying 
out section 1971 of the PHS Act: Provided further, That in addition 
to amounts provided herein, $21,039,000 shall be available under 
section 241 of the PHS Act to carry out subpart I of part B 
of title XIX of the PHS Act to fund section 1920(b) technical assist-
ance, national data, data collection and evaluation activities, and 
further that the total available under this Act for section 1920(b) 
activities shall not exceed 5 percent of the amounts appropriated 
for subpart I of part B of title XIX: Provided further, That up 
to 10 percent of the amounts made available to carry out the 
Children’s Mental Health Services program may be used to carry 
out demonstration grants or contracts for early interventions with 
persons not more than 25 years of age at clinical high risk of 
developing a first episode of psychosis: Provided further, That sec-
tion 520E(b)(2) of the PHS Act shall not apply to funds appropriated 
in this Act for fiscal year 2018: Provided further, That States 
shall expend at least 10 percent of the amount each receives for 
carrying out section 1911 of the PHS Act to support evidence- 
based programs that address the needs of individuals with early 
serious mental illness, including psychotic disorders, regardless of 
the age of the individual at onset: Provided further, That 
$100,000,000 shall be available until September 30, 2020 for grants 
to communities and community organizations who meet criteria 
for Certified Community Behavioral Health Clinics pursuant to 
section 223(a) of Public Law 113-93: Provided further, That none 
of the funds provided for section 1911 of the PHS Act shall be 
subject to section 241 of such Act: Provided further, That of the 
funds made available under this heading, $15,000,000 shall be 
to carry out section 224 of the Protecting Access to Medicare Act 
of 2014 (Public Law 113–93; 42 U.S.C. 290aa 22 note). 
SUBSTANCE ABUSE TREATMENT 
For carrying out titles III and V of the PHS Act with respect 
to substance abuse treatment and title XIX of such Act with respect 
to substance abuse treatment and prevention, $3,182,306,000: Pro-
vided, That $1,000,000,000 shall be for State Opioid Response 
Grants for carrying out activities pertaining to opioids undertaken 
by the State agency responsible for administering the substance 
abuse prevention and treatment block grant under subpart II of 
part B of title XIX of the PHS Act (42 U.S.C. 300x–21 et seq.): 
Provided further, That of such amount $50,000,000 shall be made 
available to Indian Tribes or tribal organizations: Provided further, 
That 15 percent of the remaining amount shall be for the States 
with the highest mortality rate related to opioid use disorders: 
Provided further, That of the amounts provided for State Opioid 
Response Grants not more than 2 percent shall be available for 
Federal administrative expenses, training, technical assistance, and 
evaluation: Provided further, That of the amount not reserved by 
the previous three provisos, the Secretary shall make allocations
H. R. 1625—378 
to States, territories, and the District of Columbia according to 
a formula using national survey results that the Secretary deter-
mines are the most objective and reliable measure of drug use 
and drug-related deaths: Provided further, That the Secretary shall 
submit the formula methodology to the Committees on Appropria-
tions of the House of Representatives and the Senate not less 
than 30 days prior to publishing a Funding Opportunity Announce-
ment: Provided further, That prevention and treatment activities 
funded through such grants may include education, treatment 
(including the provision of medication), behavioral health services 
for individuals in treatment programs, referral to treatment serv-
ices, recovery support, and medical screening associated with such 
treatment: Provided further, That each State, as well as the District 
of Columbia, shall receive not less than $4,000,000: Provided fur-
ther, That in addition to amounts provided herein, the following 
amounts shall be available under section 241 of the PHS Act: 
(1) $79,200,000 to carry out subpart II of part B of title XIX 
of the PHS Act to fund section 1935(b) technical assistance, national 
data, data collection and evaluation activities, and further that 
the total available under this Act for section 1935(b) activities 
shall not exceed 5 percent of the amounts appropriated for subpart 
II of part B of title XIX; and (2) $2,000,000 to evaluate substance 
abuse treatment programs: Provided further, That none of the funds 
provided for section 1921 of the PHS Act or State Opioid Response 
Grants shall be subject to section 241 of such Act. 
SUBSTANCE ABUSE PREVENTION 
For carrying out titles III and V of the PHS Act with respect 
to substance abuse prevention, $248,219,000. 
HEALTH SURVEILLANCE AND PROGRAM SUPPORT 
For program support and cross-cutting activities that supple-
ment activities funded under the headings ‘‘Mental Health’’, ‘‘Sub-
stance Abuse Treatment’’, and ‘‘Substance Abuse Prevention’’ in 
carrying out titles III, V, and XIX of the PHS Act and the Protection 
and Advocacy for Individuals with Mental Illness Act in the Sub-
stance 
Abuse 
and 
Mental 
Health 
Services 
Administration, 
$128,830,000: Provided, That in addition to amounts provided 
herein, $31,428,000 shall be available under section 241 of the 
PHS Act to supplement funds available to carry out national surveys 
on drug abuse and mental health, to collect and analyze program 
data, and to conduct public awareness and technical assistance 
activities: Provided further, That, in addition, fees may be collected 
for the costs of publications, data, data tabulations, and data anal-
ysis completed under title V of the PHS Act and provided to a 
public or private entity upon request, which shall be credited to 
this appropriation and shall remain available until expended for 
such purposes: Provided further, That amounts made available in 
this Act for carrying out section 501(m) of the PHS Act shall 
remain available through September 30, 2019: Provided further, 
That funds made available under this heading may be used to 
supplement program support funding provided under the headings 
‘‘Mental Health’’, ‘‘Substance Abuse Treatment’’, and ‘‘Substance 
Abuse Prevention’’.
H. R. 1625—379 
AGENCY FOR HEALTHCARE RESEARCH AND QUALITY 
HEALTHCARE RESEARCH AND QUALITY 
For carrying out titles III and IX of the PHS Act, part A 
of title XI of the Social Security Act, and section 1013 of the 
Medicare Prescription Drug, Improvement, and Modernization Act 
of 2003, $334,000,000: Provided, That section 947(c) of the PHS 
Act shall not apply in fiscal year 2018: Provided further, That 
in addition, amounts received from Freedom of Information Act 
fees, reimbursable and interagency agreements, and the sale of 
data shall be credited to this appropriation and shall remain avail-
able until September 30, 2019. 
CENTERS FOR MEDICARE AND MEDICAID SERVICES 
GRANTS TO STATES FOR MEDICAID 
For carrying out, except as otherwise provided, titles XI and 
XIX of the Social Security Act, $284,798,384,000, to remain avail-
able until expended. 
For making, after May 31, 2018, payments to States under 
title XIX or in the case of section 1928 on behalf of States under 
title XIX of the Social Security Act for the last quarter of fiscal 
year 2018 for unanticipated costs incurred for the current fiscal 
year, such sums as may be necessary. 
For making payments to States or in the case of section 1928 
on behalf of States under title XIX of the Social Security Act 
for the first quarter of fiscal year 2019, $134,847,759,000, to remain 
available until expended. 
Payment under such title XIX may be made for any quarter 
with respect to a State plan or plan amendment in effect during 
such quarter, if submitted in or prior to such quarter and approved 
in that or any subsequent quarter. 
PAYMENTS TO HEALTH CARE TRUST FUNDS 
For payment to the Federal Hospital Insurance Trust Fund 
and the Federal Supplementary Medical Insurance Trust Fund, 
as provided under sections 217(g), 1844, and 1860D–16 of the Social 
Security Act, sections 103(c) and 111(d) of the Social Security 
Amendments of 1965, section 278(d)(3) of Public Law 97–248, and 
for administrative expenses incurred pursuant to section 201(g) 
of the Social Security Act, $323,497,300,000. 
In addition, for making matching payments under section 1844 
and benefit payments under section 1860D–16 of the Social Security 
Act that were not anticipated in budget estimates, such sums as 
may be necessary. 
PROGRAM MANAGEMENT 
For carrying out, except as otherwise provided, titles XI, XVIII, 
XIX, and XXI of the Social Security Act, titles XIII and XXVII 
of the PHS Act, the Clinical Laboratory Improvement Amendments 
of 1988, and other responsibilities of the Centers for Medicare 
and Medicaid Services, not to exceed $3,669,744,000, to be trans-
ferred from the Federal Hospital Insurance Trust Fund and the